VanEck US Equity Buffer ETF - October

30.69

+0.14560.48%

Volume:2K

Turnover:52.20K

Market Cap:613.80K

PE:- -

High:32.83

Open:32.83

Low:30.69

Close:30.54

52wk High:32.83

52wk Low:30.51

Shares:20.00K

Float Shares:20.00K

Volume Ratio:0.12

T/O Rate:8.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

GlobeNewswire

·

Yesterday

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/OCT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCT\",,,,,undefined,":{"symbol":"OCT","market":"US","secType":"STK","nameCN":"VanEck US Equity Buffer ETF - October","latestPrice":30.69,"timestamp":1790967299563,"preClose":30.5444,"halted":0,"volume":1634,"delay":0,"changeRate":0.004766831235840341,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"Trading","change":0.1456,"latestTime":"10-02 15:30:20 EDT","open":32.83,"high":32.83,"low":30.69,"amount":52198.621834,"amplitude":0.070062,"askPrice":30.72,"askSize":100,"bidPrice":30.57,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":30.5444,"preHourTrading":{"tag":"盘前","latestPrice":30.03,"preClose":30.5444,"latestTime":"06:11 EDT","volume":21,"amount":630.63,"timestamp":1790935883800,"change":-0.5144,"changeRate":-0.016841,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":30.5444,"preClose":30.5444,"latestTime":"19:30 EDT","volume":22,"amount":684.6944,"timestamp":1790897404668,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.12085},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCT\",,,,,undefined,":{"symbol":"OCT","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.12085,"shares":20000,"dividePrice":0,"high":32.83,"amplitude":0.070062,"preClose":30.5444,"low":30.69,"week52Low":30.5094,"pbRate":"--","week52High":32.83,"institutionHeld":0,"latestPrice":30.69,"eps":0,"divideRate":0,"volume":1634,"delay":0,"ttmEps":0,"open":32.83,"prevYearClose":30.68,"prevWeekClose":30.68,"prevMonthClose":30.68,"prevQuarterClose":30.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OCT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672112037","title":"Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2672112037","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672112037?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"First patient expected to be dosed in the DUET study in the fourth quarter of 2026 Milestone triggers second closing of March 2025 private placement expected to provide approximately $95.1M in gross p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373778/0/en/surrozen-announces-fda-clearance-of-ind-application-for-szn-8141-for-the-treatment-of-diabetic-macular-edema.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMHX","BK4532","AMDC","AIS","LU2461242641.AUD","LU1861220033.SGD","FTXL","DAMD","GAMR","QQQA","AMDY","AMYY","SAMD0main","AMDD","ILDR","SOXX","OCT","BAI","IND","AMUU","AMD","BK4529","AIQ","CHAT","IETC","AMDU","CHPS","LABU","TTEQ","WUGI","LEGR","SOXY","AMDS","XNTK","CNAV","AMDG","LU2458330169.SGD","BK4575","USXF","PSI","FAI","TRFK","ARTY","AMDW","AMDL","IE00BMPRXQ63.HKD","SMH","TEK","WISE","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}